Grove Bank & Trust Bristol Myers Squibb CO Transaction History

Grove Bank & Trust

$593 Million
Q1 2024

A detailed history of Grove Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Grove Bank & Trust holds 13,033 shares of BMY stock, worth $535,916. This represents 0.12% of its overall portfolio holdings.

Number of Shares

13,033

Previous 4,815 170.67%

Holding current value

$535,916

Previous $247,000 185.83%

% of portfolio

0.12%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $394,299 - $447,059	8,218 Added 170.67%	13,033 $706,000
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $26,615 - $31,759	-549 Reduced 10.23%	4,815 $247,000
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $51,579 - $57,674	-891 Reduced 14.24%	5,364 $311,000
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $6,243 - $6,932	98 Added 1.59%	6,255 $400,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $34,629 - $39,277	527 Added 9.36%	6,157 $426,000

Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $464,636 - $550,195	-6,785 Reduced 54.65%	5,630 $405,000
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $109 - $64,852	844 Added 7.29%	12,415 $882,000
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $63,106 - $69,502	-869 Reduced 6.99%	11,571 $891,000
Q1 2022 Apr 22, 2022	BUY	$61.48 - $73.72 $256,617 - $307,707	4,174 Added 50.5%	12,440 $908,000
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $29,228 - $34,073	545 Added 7.06%	8,266 $516,000
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $59 - $69	-1 Reduced 0.01%	7,721 $457,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $2,600 - $2,831	-42 Reduced 0.54%	7,722 $516,000
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $124,495 - $140,020	-2,098 Reduced 21.27%	7,764 $490,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $60,742 - $68,832	1,052 Added 11.94%	9,862 $612,000
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $84,651 - $93,805	1,474 Added 20.09%	8,810 $532,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $88,589 - $103,569	1,616 Added 28.25%	7,336 $432,000
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $44,404 - $64,530	-957 Reduced 14.33%	5,720 $318,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $15,796 - $20,604	321 Added 5.05%	6,677 $428,000
Q3 2019 Oct 30, 2019	BUY	$42.77 - $50.71 $13,686 - $16,227	320 Added 5.3%	6,356 $322,000
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $38,730 - $42,827	-868 Reduced 12.57%	6,036 $274,000
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $451 - $538	10 Added 0.15%	6,904 $329,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $56,074 - $72,714	1,150 Added 20.02%	6,894 $358,000
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $29,526 - $33,303	-535 Reduced 8.52%	5,744 $356,000
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $145,526 - $181,382	-2,880 Reduced 31.44%	6,279 $348,000
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $13,546 - $14,769	-226 Reduced 2.41%	9,159 $561,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $518,333 - $598,199	9,385	9,385 $598,000

Others Institutions Holding BMY

# of Institutions

2,552

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account